![](https://hitconsultant.net/wp-content/uploads/2024/05/IMG_3503.png)
What you should know:
– OncoveryCare (formerly VivorCare) has closed an oversubscribed $4.5 million seed financing to launch its new cancer survivorship care model.
– The fundraising was led by .406 Ventures alongside Tennessee Oncology’s McKay Institute for Oncology Transformation. Tennessee Oncology, which treats half of Tennessee's cancer patients at 35 sites, is also a founding member of OneOncology, a fast-growing oncology platform dedicated to supporting independent oncology practices through capital, technology and to expertise.
OncoveryCare Secures Seed Funding and Partners with Tennessee Oncology to Revolutionize Cancer Survivorship Care
OncoveryCare is making strides in cancer survivorship care with its latest seed funding round, led by .406 Ventures and supported by Oncology Ventures and Techstars. Concurrently, OncoveryCare announced a strategic partnership with Tennessee Oncology, allowing the company to expand its care model to patients throughout Tennessee.
The population of cancer survivors in the United States is expected to double from 11 million in 2008 to 22 million by 2030, driven by increasing cancer incidence and improving survival rates through progress in treatments. Cancer survivors face significant post-treatment needs, including managing cardiotoxicity, cancer-related fatigue, complex screening and monitoring protocols, and mental health issues such as anxiety and depression related to their diagnosis and treatment. Despite these needs, survivorship care is often fragmented and unstructured, relying heavily on an overburdened oncology workforce, leading to high costs and suboptimal outcomes. OncoveryCare aims to fill this gap in the cancer care continuum.
Launched with a virtual care model, OncoveryCare provides a comprehensive support system for cancer survivors through a team of survivorship clinicians. Initial focus areas include toxicity management, mental health support, navigation and care planning, and preventive care. To help scale this model, OncoveryCare has partnered with the McKay Institute, the innovation arm of Tennessee Oncology, one of the nation's largest community-based cancer care providers. This partnership will help expand the intervention across Tennessee Oncology's survivor population with the broader goal of expanding it to the broader oncology community.
The seed funding will allow OncoveryCare to expand its care delivery model and develop new tools and approaches to expand access to high-quality care for survivors. By providing whole-person care, OncoveryCare supports the rapidly growing population of cancer survivors, ensuring they receive the personalized longitudinal care needed to lead healthier, happier lives.
“Survivorship is the next frontier in cancer care delivery,” explained Hil Moss, co-founder and CEO of OncoveryCare, whose own experience as a breast cancer survivor motivated her to launch the business. “For decades we have been striving to find a cure for cancer. We now need to answer the question: what happens when people survive? »